Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Fingerpaint Acquires MedThink, Adding Medical Communications to Its Suite of Capabilities

Fingerpaint, biopharma’s global commercialization partner for analytics-enabled integrated solutions, announced it acquired MedThink, a North Carolina–based company that empowers healthcare providers through medical communications. Details of the transaction were not disclosed.

The acquisition of MedThink will bring extensive medical communications capabilities to Fingerpaint through 2 distinct divisions: MedThink SciCom, which harnesses deep scientific knowledge and extensive industry experience to develop solutions for medical affairs, medical communications, and publication groups; and MedThink Communications, which provides medical education and marketing services that influence perception and change the behavior of healthcare professionals to commercial teams of all sizes.

Recommended AI News: proteanTecs Expands into Mobile and Boosts Management to Accommodate Growth


“Adding to our capabilities as our clients’ needs evolve has always been a priority for Fingerpaint,” said Ed Mitzen, founder of Fingerpaint. “Medical communications and education have never been more important than they are now given the ever-changing ways we reach healthcare stakeholders and the growing need to convey increasingly complex science behind many of today’s therapies to ensure people have access to them.”

Scott Goudy, president of MedThink, will continue to lead day-to-day operations.

Related Posts
1 of 38,307

“Joining Fingerpaint will accelerate our mission of moving minds, moving markets, and moving medicine by leveraging the company’s capabilities at every step of the commercialization process,” said Goudy. “We are looking forward to creating new opportunities for our clients and our people.”

Recommended AI News: Cryptocurrency Mining in Bitcoin Hits All Time High

Knox Lane, a private equity firm based in San Francisco, is a strategic investor in Fingerpaint.

“This acquisition will expand the company’s service offerings and talent into an area we know is critical to the industry and will solidify Fingerpaint’s position as biopharma’s leading commercialization partner,” said Shamik Patel, partner at Knox Lane.

MedThink joins integrated Fingerpaint firms Leaderboard Branding, a leading global naming and branding business; 1798, a market access and commercialization firm that specializes in healthcare consulting services, including patient and provider access services; and Photo 51, a consultancy focused solely on advanced therapeutics, such as gene and cell therapies.

Recommended AI News: Block Ape Scissors Announce Official Beta Launch Date

[To share your insights with us, please write to]

Comments are closed.